BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38488994)

  • 1. Multiple surgical resections for progressive IDH wildtype glioblastoma-is it beneficial?
    Honeyman SI; Owen WJ; Mier J; Marks K; Dassanyake SN; Wood MJ; Fairhead R; Martinez-Soler P; Jasem H; Yarlagadda A; Roach JR; Boukas A; Stacey R; Apostolopoulos V; Plaha P
    Acta Neurochir (Wien); 2024 Mar; 166(1):138. PubMed ID: 38488994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple resections for patients with glioblastoma: prolonging survival.
    Chaichana KL; Zadnik P; Weingart JD; Olivi A; Gallia GL; Blakeley J; Lim M; Brem H; Quiñones-Hinojosa A
    J Neurosurg; 2013 Apr; 118(4):812-20. PubMed ID: 23082884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients.
    Yan JL; van der Hoorn A; Larkin TJ; Boonzaier NR; Matys T; Price SJ
    J Neurosurg; 2017 Jan; 126(1):234-241. PubMed ID: 27058207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients.
    Hallaert G; Pinson H; Vanhauwaert D; Van den Broecke C; Van Roost D; Boterberg T; Kalala JP
    Surg Oncol; 2020 Dec; 35():515-519. PubMed ID: 33152608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the efficacy of repeat resections in recurrent glioblastoma: a systematic review.
    Botros D; Dux H; Price C; Khalafallah AM; Mukherjee D
    Neurosurg Rev; 2021 Jun; 44(3):1259-1271. PubMed ID: 32533385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
    Goldman DA; Hovinga K; Reiner AS; Esquenazi Y; Tabar V; Panageas KS
    J Neurosurg; 2018 Nov; 129(5):1231-1239. PubMed ID: 29303449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?
    Pala A; Schmitz AL; Knoll A; Schneider M; Hlavac M; König R; Wirtz CR; Coburger J
    Clin Neurol Neurosurg; 2018 Apr; 167():6-10. PubMed ID: 29425743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Craniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years.
    Mukherjee S; Wood J; Liaquat I; Stapleton SR; Martin AJ
    Clin Neurol Neurosurg; 2020 Jan; 188():105568. PubMed ID: 31739155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis.
    Perrini P; Gambacciani C; Weiss A; Pasqualetti F; Delishaj D; Paiar F; Morganti R; Vannozzi R; Lutzemberger L
    J Neurooncol; 2017 Feb; 131(3):585-591. PubMed ID: 27844310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors influencing survival following re-resection for isocitrate dehydrogenase (IDH) -wildtype glioblastoma multiforme - Data from a national neuro-oncology registry.
    Hennessy MA; Coyne ZL; O'Halloran PJ; Mullally W; Dablouk M; MacNally S; Morris PG
    J Clin Neurosci; 2022 Jan; 95():142-150. PubMed ID: 34929638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and functional status after resection of recurrent glioblastoma multiforme.
    Barker FG; Chang SM; Gutin PH; Malec MK; McDermott MW; Prados MD; Wilson CB
    Neurosurgery; 1998 Apr; 42(4):709-20; discussion 720-3. PubMed ID: 9574634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
    Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
    Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival after reoperation for recurrent glioblastoma.
    Woodroffe RW; Zanaty M; Soni N; Mott SL; Helland LC; Pasha A; Maley J; Dhungana N; Jones KA; Monga V; Greenlee JDW
    J Clin Neurosci; 2020 Mar; 73():118-124. PubMed ID: 31987636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
    Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
    Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Early Reoperation on the Prognosis of Patients Operated on for Glioblastoma.
    Troya-Castilla M; Kaen A; Márquez-Rivas FJ; Infante-Cossio P; Rius Díaz F; Narros Gimenez JL; Gonzalez-Pombo M; Cancela P; Segura Fernández-Nogueras M; Arráez Sánchez MÁ
    World Neurosurg; 2020 Jul; 139():e592-e600. PubMed ID: 32330620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection.
    Ringel F; Pape H; Sabel M; Krex D; Bock HC; Misch M; Weyerbrock A; Westermaier T; Senft C; Schucht P; Meyer B; Simon M;
    Neuro Oncol; 2016 Jan; 18(1):96-104. PubMed ID: 26243790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
    Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
    J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of tumor resection for recurrent glioblastoma.
    Quick J; Gessler F; Dützmann S; Hattingen E; Harter PN; Weise LM; Franz K; Seifert V; Senft C
    J Neurooncol; 2014 Apr; 117(2):365-72. PubMed ID: 24535317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.